Alcohol and drugs in epilepsy: Pathophysiology, presentation, possibilities, and prevention

Epilepsia

Volumn 53, Issue SUPPL. 4, 2012, Pages 48-57

  Leach, John Paul ^a   Mohanraj, Rajiv ^b   Borland, William ^c  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

Alcohol; Dependency; Provoked seizures

Indexed keywords

4 HYDROXYBUTYRIC ACID; ALCOHOL; BACLOFEN; BENZODIAZEPINE DERIVATIVE; CANNABIS; CARBAMAZEPINE; CHLORDIAZEPOXIDE; CLOMETHIAZOLE; COCAINE; DIAZEPAM; ETIRACETAM; FLUMAZENIL; GABAPENTIN; KETAMINE; LAMOTRIGINE; LORAZEPAM; METHADONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENYTOIN; TOPIRAMATE; TRAMADOL; VALPROIC ACID;

AGITATION; ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ALCOHOL WITHDRAWAL; ARTICLE; BRAIN METABOLISM; CANNABIS ADDICTION; COCAINE DEPENDENCE; CONFUSION; DELIRIUM TREMENS; DEPERSONALIZATION; DEPRESSION; DROWSINESS; DRUG DEPENDENCE; DRUG SAFETY; DRUG WITHDRAWAL; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; GABAERGIC SYSTEM; GENERALIZED EPILEPSY; HUMAN; INSOMNIA; IRRITABILITY; LIVER FUNCTION TEST; MUSCLE SPASM; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SEIZURE THRESHOLD; SIDE EFFECT; SOMNOLENCE; SWEATING; TREMOR; WERNICKE KORSAKOFF SYNDROME; WITHDRAWAL SEIZURE;

ALCOHOL DRINKING; ALCOHOL WITHDRAWAL SEIZURES; ALCOHOLISM; AMPHETAMINE-RELATED DISORDERS; BENZODIAZEPINES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; COCAINE-RELATED DISORDERS; EPILEPSY; ETHANOL; GAMMA-AMINOBUTYRIC ACID; HEROIN DEPENDENCE; HUMANS; KETAMINE; MARIJUANA ABUSE; SEIZURES; SUBSTANCE-RELATED DISORDERS;

EID: 84865707919     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2012.03613.x     Document Type: Article

References (88)

1. Aitchison KJ, Tsapakis EM, Huezo-Diaz P, Kerwin RW, Forsling ML, Wolff K,. (2012) Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT. J Psychopharmacol 26: 408-418.
2. Alger BE,. (2004) Endocannabinoids and their implications for epilepsy. Epilepsy Curr 4: 169-173.
3. Alldredge BK, Lowenstein DH,. (1993) Status epilepticus related to alcohol abuse. Epilepsia 34: 1033-1037. (Pubitemid 24004240)
4. Alldredge BK, Lowenstein DH, Simon RP,. (1989) Seizures associated with recreational drug abuse. Neurology 39: 1037-1039. (Pubitemid 19217470)
5. Amato L, Minozzi S, Davoli M,. (2011) Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome. Cochrane Database Syst Rev 6: CD008537.
6. Anderson P,. (1985) Managing alcohol problems in general practice. Br Med J (Clin Res Ed) 290: 1873-1875. (Pubitemid 15062852)
7. Bayard M, Hill KR, Woodside J,. (2004) Alcohol withdrawal syndrome. Am Fam Physician 69: 1443-1450. (Pubitemid 38380765)
8. Ben-Abraham R, Szold O, Rudick V, Weinbroum AA,. (2003) 'Ecstasy' intoxication: life-threatening manifestations and resuscitative measures in the intensive care setting. Eur J Emerg Med 10: 309-313.
9. Bhaskaran MD, Smith BN,. (2010) Cannabinoid-mediated inhibition of recurrent excitatory circuitry in the dentate gyrus in a mouse model of temporal lobe epilepsy. PLoS ONE 5: 10683.
10. Bleich S, Bayerlein K, Reulbach U, Hillemacher T, Bönsch D, Mugele B, Kornhuber J, Sperling W,. (2004) Homocysteine levels in patients classified according to Lesch's typology. Alcohol Alcohol 39: 493-498. (Pubitemid 39534530)
11. Bodnar RJ,. (2011) Endogenous opiates and behavior: 2010. Peptides 32: 2522-2552.
12. Brvar M, Kozelj G, Osredkar J, Mozina M, Gricar M, Bunc M,. (2004) Polydipsia as another mechanism of hyponatremia after 'ecstasy' (3,4 methyldioxymethamphetamine) ingestion. Eur J Emerg Med 11: 302-304.
13. Chen WH, Yin HL, Lin HS, Chen SS, Liu JS,. (2006) Delayed hypokalemic paralysis following a convulsion due to alcohol abstinence. J Clin Neurosci 13: 453-456.
14. Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B, WHO/ISBRA Study Group. (2002) CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res 26: 332-339. (Pubitemid 34225837)
15. Consroe PF, Wood GC, Buchsbaum H,. (1975) Anticonvulsant nature of marihuana smoking. JAMA 234: 306-307.
16. Degenhardt L, Hall W,. (2012) Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 379: 55-70.
17. Devlin RJ, Henry JA,. (2008) Clinical review: major consequences of illicit drug consumption. Crit Care 12: 202.
18. Ellison JM, Gelwan E, Ogletree J,. (1990) Complex partial seizure symptoms affected by marijuana abuse. J Clin Psychiatry 51: 439-440. (Pubitemid 20359861)
19. Feng Y, He X, Yang Y, Chao D, Lazarus LH, Xia Y,. (2012) Current research on opioid receptor function. Curr Drug Targets 13: 230-246.
20. Gardner H, Lawn N, Fatovich DM, Archer JS,. (2009) Acute hippocampal sclerosis following ecstasy ingestion. Neurology 73: 567-569.
21. Ghatol A, Kazory A,. (2012) Ecstasy-associated acute severe hyponatremia and cerebral edema: a role for osmotic diuresis? J Emerg Med 42: 137-140.
22. Giorgi FS, Lazzeri G, Natale G, Iudice A, Ruggieri S, Paparelli A, Murri L, Fornai F,. (2006) MDMA and seizures: a dangerous liaison? Ann N Y Acad Sci 1074: 357-364. (Pubitemid 44532840)
23. Goffin K, Van Paesschen W, Van Laere K,. (2011) In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis. Brain 134: 1033-1040.
24. Gordon E, Devinsky O,. (2001) Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy. Epilepsia 42: 1266-1272. (Pubitemid 33070666)
25. Gouzoulis-Mayfrank E, Daumann J,. (2006) Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage? Addiction 101: 348-361. (Pubitemid 43344818)
26. Grant I, Rael Cahn B,. (2005) Cannabis and endocannabinoid modulators: therapeutic promises and challenges. Clin Neurosci Res 5: 185-199. (Pubitemid 41671147)
27. Green AR, O'shea E, Colado MI,. (2004) A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response. Eur J Pharmacol 500: 3-13. (Pubitemid 39303992)
28. Griffiths RR, Wolf B,. (1990) Relative abuse liability of different benzodiazepines in drug abusers. J Clin Psychopharmacol 10: 237-243. (Pubitemid 20319176)
29. Gŕnlykke L, Knudsen ML, H́genhaven H, Moltke FB, Madsen FF, Kjaer TW,. (2008) Remifentanil-induced spike activity as a diagnostic tool in epilepsy surgery. Acta Neurol Scand 117: 90-93.
30. Hartung TK, Schofield E, Short AI, Parr MJ, Henry JA,. (2002) Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') ingestion. QJM 95: 431-437. (Pubitemid 34814661)
31. Henriksen G, Willoch F,. (2008) Imaging of opioid receptors in the central nervous system. Brain 131: 1171-1196.
32. Hillbom M, Pieninkeroinen I, Leone M,. (2003) Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management. CNS Drugs 17: 1013-1030. (Pubitemid 37463820)
33. Hofmann ME, Frazier CJ,. (2011) Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention. Exp Neurol Dec 9 [Epub ahead of print].
34. Hughes JR,. (2009) Alcohol withdrawal seizures. Epilepsy Behav 15: 92-97.
35. Jick H, Derby LE, Vasilakis C, Fife D,. (1998) The risk of seizures associated with tramadol. Pharmacotherapy 18: 607-611. (Pubitemid 28228343)
36. Jones NA, Hill AJ, Smith I, Bevan SA, Williams CM, Whalley BJ, Stephens GJ,. (2010) Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo. J Pharmacol Exp Ther 332: 569-577.
37. Jonsson S, O'Meara M, Young JB,. (1983) Acute cocaine poisoning. Importance of treating seizures and acidosis. Am J Med 75: 1061-1064. (Pubitemid 14204600)
38. Kalantar-Zadeh K, Nguyen MK, Chang R, Kurtz I,. (2006) Fatal hyponatremia in a young woman after ecstasy ingestion. Nat Clin Pract Nephrol 2: 283-288. (Pubitemid 43787261)
39. Keeler MH, Reifler CB,. (1967) Grand mal convulsions subsequent to marijuana use. Case report. Dis Nerv Syst 28: 474-475.
40. Kobayashi T, Ikeda K, Kojima H, Niki H, Yano R, Yoshioka T, Kumanishi T,. (1999) Ethanol opens G-protein-activated inwardly rectiying K+ channels. Nat Neurosci 2: 1091-1097. (Pubitemid 30126367)
41. Koppel BS, Samkoff L, Daras M,. (1996) Relation of cocaine use to seizures and epilepsy. Epilepsia 37: 875-878. (Pubitemid 26313734)
42. Kraemer KL, Conigliaro J, Saitz R,. (1999) Managing alcohol withdrawal in the elderly. Drugs Aging 14: 409-425. (Pubitemid 29281299)
43. Liechti M, Kunz I, Greminger P, Speich R, Kupferschmidt H,. (2006) Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. Drug Alcohol Depend 81: 323-326. (Pubitemid 43152459)
44. Lowenstein DH, Massa SM, Rowbotham MC, Collins SD, McKinney HE, Simon RP,. (1987) Acute neurologic and psychiatric complications associated with cocaine abuse. Am J Med 83: 841-846. (Pubitemid 18098157)
45. Macêdo DS, Santos RS, Belchior LD, Neto MA, Vasconcelos SM, Lima VT, Fonteles MM, Viana GS, de Sousa FC,. (2004) Effect of anxiolytic, antidepressant, and antipsychotic drugs on cocaine-induced seizures and mortality. Epilepsy Behav 5: 852-856. (Pubitemid 40003905)
46. Majlesi N, Shih R, Fiesseler FW, Hung O, Debellonio R,. (2010) Cocaine-associated seizures and incidence of status epilepticus. West J Emerg Med 11: 157-160.
47. Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Gutiérrez SO, van der Stelt M, Lõpez-Rodriguez ML, Casanova E, Schütz G, Zieglgänsberger W, Di Marzo V, Behl C, Lutz B,. (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302: 84-88. (Pubitemid 37210691)
48. Matthai SM, Davidson DC, Sills JA, Alexandrou D,. (1996) Cerebral oedema after ingestion of MDMA ("ecstasy") and unrestricted intake of water. BMJ 312: 1359. (Pubitemid 26158319)
49. Mattoo SK, Singh SM, Bhardwaj R, Kumar S, Basu D, Kulhara P,. (2009) Prevalence and correlates of epileptic seizure in substance-abusing subjects. Psychiatry Clin Neurosci 63: 580-582.
50. Maxwell JC,. (2008) Are we becoming more alike? Comparison of substance use in Australia and the United States as seen in the 1995, 1998, 2001 and 2004 national household surveys. Drug Alcohol Rev 27: 473-481.
51. Mayo-Smith MF,. (1997) Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 278: 144-151.
52. McDonough M, Kennedy N, Glasper A, Bearn J,. (2004) Clincial features of gamma-hydroxybutyrate withdrawal: a review. Drug Alcohol Depend 75: 3-9. (Pubitemid 38844572)
53. McGuire G, El-Beheiry H, Manninen P, Lozano A, Wennberg R,. (2003) Activation of electrocorticographic activity with remifentanil and alfentanil during neurosurgical excision of epileptogenic focus. Br J Anaesth 91: 651-655. (Pubitemid 37369524)
54. McInnes GT,. (1987) Chlormethiazole and alcohol: a lethal cocktail. Br Med J (Clin Res Ed) 294: 592. (Pubitemid 17028135)
55. Merkel PA, Koroshetz WJ, Irizarry MC, Cudkowicz ME,. (1995) Cocaine-associated cerebral vasculitis. Semin Arthritis Rheum 25: 172-183. (Pubitemid 26001343)
56. Ng SK, Brust JC, Hauser WA, Susser M,. (1990) Illicit drug use and the risk of new-onset seizures. Am J Epidemiol 132: 47-57. (Pubitemid 20203302)
57. Nifoş F, Martinuzzi A, Toffanin T, Costanzo R, Vestri A, Battaglia M, Bertagnoni GE, Lupi A, Amistã P, Carollo C, Perini G,. (2009) Hippocampal remodelling after MDMA neurotoxicity: a single case study. World J Biol Psychiatry 10: 4 Pt 3): 961-968.
58. O'Dell LE, Kreifeldt MJ, George FR, Ritz MC,. (2000) The role of serotonin (2) receptors in mediating cocaine-induced convulsions. Pharmacol Biochem Behav 65: 677-681. (Pubitemid 30182512)
59. Parkinson SK, Bailey SL, Little WL, Mueller JB,. (1990) Myoclonic seizure activity in chronic high-dose spinal opioid administration. Anesthesiology 72: 743-745. (Pubitemid 20114723)
60. Pascual-Leone A, Dhuna A, Altafullah I, Anderson DC,. (1990) Cocaine-induced seizures. Neurology 40: 3 Pt 1): 404-407. (Pubitemid 20117518)
61. Patel MM, Belson MG, Longwater AB, Olson KR, Miller MA,. (2005) Methylenedioxymethamphetamine (ecstasy)-related hyperthermia. J Emerg Med 29: 451-454. (Pubitemid 41501576)
62. Pinel JP,. (1980) Alcohol withdrawal seizures: implications of kindling. Pharmacol Biochem Behav 13 (Suppl. 1): 225-231.
63. Pozzi M, Roccatagliata D, Sterzi R,. (2008) Drug abuse and intracranial hemorrhage. Neurol Sci 29 (Suppl. 2): S269-S270.
64. Rathlev NK, Ulrich A, Shieh TC, Callum MG, Bernstein E, D'Onofrio G,. (2002) Etiology and weekly occurrence of alcohol-related seizures. Acad Emerg Med 9: 824-828. (Pubitemid 34856300)
65. Rogawski M,. (2005) Current review of basic science. Epilepsy Curr 5: 225-230.
66. Rosenson J, Smollin C, Sporer KA, Blanc P, Olson KR,. (2007) Patterns of ecstasy-associated hyponatremia in California. Ann Emerg Med 49: 164-171.
67. Rustembegovic A, Sofic E, Kroyer G,. (2002) A pilot study of topiramate (Topamax) in the treatment of tonic-clonic seizures of alcohol withdrawal syndromes. Med Arh 56: 211-212.
68. Saboory E, Derchansky M, Ismaili M, Jahromi SS, Brull R, Carlen PL, El Beheiry H,. (2007) Mechanisms of morphine enhancement of spontaneous seizure activity. Anesth Analg 105: 1729-1735. (Pubitemid 350190571)
69. Schifano F, Corkery J, Deluca P, Oyefeso A, Ghodse AH,. (2006) Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003). J Psychopharmacol 20: 456-463.
70. Scotter EL, Abood ME, Glass M,. (2010) The endocannabinoid system as a target for the treatment of neurodegenerative disease. Br J Pharmacol 160: 480-498.
71. Scottish Executive Health Department. (2002) Plan for action on alcohol problems. The Department, Edinburgh. Available from URL: http://www. alcoholinformation.isdscotland.org/alcohol-misuse (accessed 11 August 2003).
72. Serfaty M, Masterton G,. (1993) Fatal poisonings attributed to benzodiazepines in Britain during the 1980s. Br J Psychiatry 163: 386-389.
73. Sharma HS, Muresanu D, Sharma A, Patnaik R,. (2009) Cocaine-induced breakdown of the blood-brain barrier and neurotoxicity. Int Rev Neurobiol 88: 297-334.
74. Shih CJ, Doufas AG, Chang HC, Lin CM,. (2005) Recurrent seizure activity after epidural morphine in a post-partum woman. Can J Anaesth 52: 727-729. (Pubitemid 41655574)
75. SIGN Guideline No 74. (2003) Management of harmful drinking and alcohol dependence in Adults 2003. http://www.sign.ac.uk.
76. Spivey WH, Euerle B,. (1990) Neurologic complications of cocaine abuse. Ann Emerg Med 19: 1422-1428.
77. Sporer KA, Firestone J,. (1997) Clinical course of crack cocaine body stuffers. Ann Emerg Med 29: 596-601. (Pubitemid 27187704)
78. Steele MT, Westdorp EJ, Garza AG, Ma OJ, Roberts DK, Watson WA,. (2000) Screening for stimulant use in adult emergency department seizure patients. J Toxicol Clin Toxicol 38: 609-613.
79. Talaie H, Panahandeh R, Fayaznouri M, Asadi Z, Abdollahi M,. (2009) Dose-independent occurrence of seizure with tramadol. J Med Toxicol 5: 63-67.
80. Temkin NR,. (2001) Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 42: 515-524. (Pubitemid 32322197)
81. Tortella FC, Robles L, Mosberg HI,. (1987) Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures. J Pharmacol Exp Ther 240: 571-577. (Pubitemid 17018442)
82. van Rijn CM, Perescis MF, Vinogradova L, van Luijtelaar G,. (2011) Endocannabinoid system protects against cryptogenic seizures. Pharmacol Rep 63: 165-168.
83. Walter H, Messing RO,. (1999) Regulation of neuronal voltage-gated calcium channels by ethanol. Neurochem Int 35: 95-101. (Pubitemid 29261705)
84. Warner-Smith M, Darke S, Day C,. (2002) Morbidity associated with non-fatal heroin overdose. Addiction 97: 963-967.
85. Watson WP, Robinson E, Little HJ,. (1997) The novel anticonvulsant, gabapentin, protects against both convulsant and anxiogenic aspect of the ethanol withdrawal syndrome. Neuropharmacology 36: 1369-1375. (Pubitemid 27502194)
86. Wolff K, Tsapakis EM, Winstock AR, Hartley D, Holt D, Forsling ML, Aitchison KJ,. (2006) Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population. J Psychopharmacol 20: 400-410.
87. Yajima Y, Narita M, Takahashi-Nakano Y, Misawa M, Nagase H, Mizoguchi H, Tseng LF, Suzuki T,. (2000) Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse. Brain Res 862: 120-126. (Pubitemid 30229777)
88. Zagnoni PG, Albano C,. (2002) Psychostimulants and epilepsy. Epilepsia 43 (Suppl. 2): 28-31. (Pubitemid 34229483)